These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11783394)

  • 41. An improved risk of malignancy index in diagnosis of adnexal mass.
    Wang LM; Song H; Song X; Zhou XB
    Chin Med J (Engl); 2012 Feb; 125(3):533-5. PubMed ID: 22490416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index.
    Davies AP; Jacobs I; Woolas R; Fish A; Oram D
    Br J Obstet Gynaecol; 1993 Oct; 100(10):927-31. PubMed ID: 8217976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk Malignancy Index (RMI) in patients with abnormal pelvic mass: Comparing RMI 1, 2 and 3 in an Australian population.
    Kader Ali Mohan GR; Jaaback K; Proietto A; Robertson R; Angstetra D
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):77-80. PubMed ID: 20219002
    [No Abstract]   [Full Text] [Related]  

  • 44. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers.
    Bast RC; Skates S; Lokshin A; Moore RG
    Int J Gynecol Cancer; 2012 May; 22 Suppl 1(Suppl 1):S5-8. PubMed ID: 22543921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preoperative evaluation and triage of women with suspicious adnexal masses using risk of malignancy index.
    Enakpene CA; Omigbodun AO; Goecke TW; Odukogbe AT; Beckmann MW
    J Obstet Gynaecol Res; 2009 Feb; 35(1):131-8. PubMed ID: 19215560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A proposal for a new scoring system to evaluate pelvic masses: Pelvic Masses Score (PMS).
    Rossi A; Braghin C; Soldano F; Isola M; Capodicasa V; Londero AP; Forzano L; Marchesoni D
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):84-8. PubMed ID: 21440361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparisons of Effectiveness in Differentiating Benign from Malignant Ovarian Masses between Conventional and Modified Risk of Malignancy Index (RMI).
    Tantipalakorn C; Tinnangwattana D; Lerthiranwong T; Luewan S; Tongsong T
    Int J Environ Res Public Health; 2023 Jan; 20(1):. PubMed ID: 36613208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A preliminary study: The sequential use of the risk malignancy index and contrast-enhanced ultrasonography in differential diagnosis of adnexal masses.
    Qiu L; Yang F; Luo H
    Medicine (Baltimore); 2018 Jul; 97(29):e11536. PubMed ID: 30024542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive Value of Malignancy Risk Indices for Ovarian Masses in Premenopausal and Postmenopausal Women.
    Ertas S; Vural F; Vural F; Tufekci EC; Ertas AC; Kose G; Aka N
    Asian Pac J Cancer Prev; 2016; 17(4):2177-83. PubMed ID: 27221915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study.
    Van Calster B; Valentin L; Froyman W; Landolfo C; Ceusters J; Testa AC; Wynants L; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Savelli L; Fischerová D; Czekierdowski A; Kaijser J; Coosemans A; Scambia G; Vergote I; Bourne T; Timmerman D
    BMJ; 2020 Jul; 370():m2614. PubMed ID: 32732303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay.
    Bristow RE; Smith A; Zhang Z; Chan DW; Crutcher G; Fung ET; Munroe DG
    Gynecol Oncol; 2013 Feb; 128(2):252-9. PubMed ID: 23178277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of malignancy index as an evaluation of preoperative pelvic mass.
    Bouzari Z; Yazdani S; Shirkhani Kelagar Z; Abbaszadeh N
    Caspian J Intern Med; 2011; 2(4):331-5. PubMed ID: 24551441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses.
    Chen X; Zhou H; Chen R; He J; Wang Y; Huang L; Sun L; Duan C; Luo X; Yan H
    Clin Chim Acta; 2015 Feb; 440():57-63. PubMed ID: 25447698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preoperative assessment of ovarian tumors by CA 125 measurement and transvaginal color Doppler ultrasound.
    Kupesić S; Vujisić S; Kurjak A; Mihaljević D; Radosević S
    Acta Med Croatica; 2002; 56(1):3-10. PubMed ID: 12455447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Triage of ovarian masses.
    Chia YN; Marsden DE; Robertson G; Hacker NF
    Aust N Z J Obstet Gynaecol; 2008 Jun; 48(3):322-8. PubMed ID: 18532966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of three malignancy risk indices and CA-125 in the preoperative evaluation of patients with pelvic masses.
    Bouzari Z; Yazdani S; Ahmadi MH; Barat S; Kelagar ZS; Kutenaie MJ; Abbaszade N; Khajat F
    BMC Res Notes; 2011 Jun; 4():206. PubMed ID: 21689405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer.
    Olivier RI; Lubsen-Brandsma MA; Verhoef S; van Beurden M
    Gynecol Oncol; 2006 Jan; 100(1):20-6. PubMed ID: 16188302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma].
    Sheng XG; Zhang XL; Fu Z; Li HQ; Li QS; Ma ZF; Li DP; Chen ZY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):460-3. PubMed ID: 17961335
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reliability of preoperative evaluation of postmenopausal ovarian tumors.
    Niemi RJ; Saarelainen SK; Luukkaala TH; Mäenpää JU
    J Ovarian Res; 2017 Mar; 10(1):15. PubMed ID: 28288666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.